BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01) | Apply Online

Frequently Asked Questions (FAQs)

What is the BRAIN Initiative U01 funding opportunity (RFA-NS-16-007) trying to support?

This NIH cooperative agreement supports the optimization of transformative neurotechnologies for large-scale recording and modulation in the nervous system. The goal is to move promising tools beyond early proof-of-concept into a mature stage where they can be used reliably by the broader neuroscience community.

What does "optimization" mean in the context of this program?

Optimization here means improving tools that already showed clear promise in initial proof-of-concept testing. The program emphasizes iterative refinement in real experimental settings, using cycles of development, testing, user feedback, and redesign so the technology becomes robust, higher-performing, easier to use, and better aligned with real research workflows.

Is this funding meant for brand-new, exploratory inventions?

No. The opportunity is aimed at technologies that have already demonstrated transformative potential during proof-of-concept testing. It focuses on practical improvement and readiness for broader adoption rather than purely exploratory inventions that have not yet been demonstrated.

What types of technologies are in scope?

Technologies in scope include hardware and software advances for large-scale neural recording and neural modulation. The FOA targets tools that can record activity and manipulate neural circuits at or near cellular resolution, across multiple spatial and temporal scales, in any brain region, and through the full depth of the brain.

What kinds of performance improvements does the FOA emphasize?

The FOA highlights improvements that address major challenges in large-scale recording and modulation, including better signal quality, broader spatial coverage, improved temporal precision, improved access to deep brain regions, long-term stability, usability, and smoother integration with experimental workflows.

What does "iterative refinement" look like for applicants?

Applicants are expected to take a technology with demonstrated potential and improve it through repeated cycles: develop, test in relevant settings, gather direct input from intended users, and revise the technology based on that feedback. The emphasis is on practical iteration rather than one-time development.

Does the opportunity support software development, or only devices?

It supports both. The FOA includes hardware and software advances, such as improving analysis pipelines and user interfaces, alongside engineering improvements to devices and systems.

What kind of work does NIH expect to accelerate under this program?

The FOA explicitly aims to accelerate development that often involves engineering-focused efforts such as improving reliability, establishing standardized and reproducible fabrication methods, enhancing analysis pipelines and interfaces, and validating performance in relevant biological contexts.

Why is usability and community adoption so central to this program?

The program is based on the idea that inventing a tool is only the first step. For a technology to change how neuroscience is done, it must be iteratively improved with direct input from the scientists who will use it, and it must be dependable and easy to integrate into routine experiments.

Does the FOA address manufacturing and distribution, or only technical performance?

Yes, it addresses manufacturing and distribution. A major component is scaling manufacturing and dissemination so the tools can be sustainably produced, distributed broadly, and used outside a single lab with minimal friction.

What is the funding mechanism, and what does it imply?

The mechanism is a U01 cooperative agreement. This typically implies substantial involvement from NIH program staff compared to a standard investigator-initiated grant, along with expectations for coordination, milestone-driven progress, and deliverables that support broad community adoption.

Who is the sponsoring agency?

The sponsoring agency is HHS-NIH (National Institutes of Health within the U.S. Department of Health and Human Services).

What are the CFDA numbers associated with this opportunity?

The program is associated with multiple CFDA numbers: 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, and 93.867.

When was this opportunity posted and when did it close?

The original posting date was November 17, 2015, and the listed closing date was February 24, 2016.

What types of organizations are eligible to apply?

Eligibility is broad and includes: state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other Native American tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations other than small businesses; and small businesses.

Are for-profit companies eligible, including small businesses?

Yes. The eligibility list includes for-profit organizations other than small businesses, and also explicitly includes small businesses.

Are academic institutions eligible?

Yes. Public and state-controlled institutions of higher education and private institutions of higher education are both listed as eligible applicants.

Are government and tribal entities eligible?

Yes. Eligible applicants include multiple levels of government (state, county, city, township, special districts), as well as federally recognized Native American tribal governments and other Native American tribal organizations.

What is the program trying to achieve in the "middle ground" between invention and adoption?

The FOA targets the stage where a promising tool needs practical optimization to become dependable, reproducible, manufacturable, and broadly usable. It is designed to help technologies transition from impressive prototypes into platforms that can be routinely deployed across the neuroscience community.

What is the expected end result of projects funded under this FOA?

The expected outcome is not just incremental improvement, but practical optimization that makes tools reliable and scalable: robust performance, reproducible methods, sustainable manufacturing and distribution, and broad usability for recording from and modulating neural circuits at high resolution across large populations of cells and throughout the brain.